The National Pharmaceutical Pricing Authority also called as NPPA has fixed retail prices of 59 formulations under Drugs (Prices Control) Order, 2013 in relating to 70th Authority meeting held recently. National Pharmaceutical Pricing Authority is an independent body of experts who have been entrusted with the task of fixation/revision of prices of pharmaceutical products enforcement of provisions of the Drugs (Prices Control) Order and monitoring of the prices of controlled and decontrolled drugs in the country.
If a manufacturer sells a medicine above the price approved by the Government, or, in other words, the MRP breaching ceiling price plus applicable local taxes would be tantamount to overcharging the consumer, which is liable to be recovered along with interest thereon from the date of overcharging. The excess collection on account of overcharging along with interest is recoverable as arrears to land revenue under the Public Demand Recovery Act.
In the order released, the drugs with their brand names marketed and manufactured by various pharmaceutical companies are mentioned with their ceiling prices.
The order issued by the NPPA is attached below for reference including all the drug formulations.
Source: NPPA Website and PlexusMD Research